Drug Discovery for Psychiatric Disorders PDF ePub eBook

Books Info:

Drug Discovery for Psychiatric Disorders free pdf The discovery and development of effective medicines for the treatment of psychiatric disorders such as schizophrenia and depression has been heralded as one of the great medical achievements of the past century. Indeed, the profound impact of these medicines on our understanding of the pathophysiology underlying these diseases, the treatment of psychiatric patients and even our social perception of mental illnesses cannot be underestimated. However, there is still an urgent medical need for even more effective, safe and well-tolerated treatments. For example, currently available treatments for schizophrenia address mainly the positive symptoms and largely neglect the negative symptoms and cognitive disfunction which greatly impact overall morbidity. Similarly, whilst the current first line antidepressants show significantly improved side effect profiles compared to the first generation therapies, there still up to 40% of patients who are treatment resistant, and even in the patient population which responds well, the onset of action is slow at typically 2-3 weeks. The aim of this book is to provide the first point of call for those involved or just interested in this rapidly expanding and increasingly fragmented field of research and drug discovery. The editors will combine their wide ranging experience and extensive network of contacts with leading scientists and opinion leaders in this field to provide an authoritative reference text covering the evolution, major advances, challenges and future directions in drug discovery and medicinal chemistry for major psychiatric disorders.

About Zoran Rankovic

Zoran Rankovic is a Senior Research Fellow and a Head of Medicinal Chemistry section at MSD, Merck Research Laboratories, U.K. 15 years experience in drug discovery with a track record of delivering compounds into the development for a number of therapeutic areas, including psychiatry. Over a decade of a direct involvement in shaping the early discovery portfolio for the neuroscience franchise. Zoran has a PhD in organic chemistry from the University of Leeds, UK. Richard Hargreaves is Vice President and Worldwide Head of Neuroscience Discovery Research at Merck - completed his doctorate through the Physiology Department at King's College London University UK. Joined Merck's Neuroscience Research Center in Harlow UK in 1988. Leader of the discovery biology teams that contributed to the development of MAXALT(R) (rizatriptan) for the treatment of migraine and EMEND(R) (aprepitant) and IVEMEND(R) (fosaprepitant), novel agents that advance the protective pharmacotherapy of acute and delayed chemotherapy-induced nausea and vomiting and post-operative nausea and vomiting. In 1999 he became Vice President Worldwide Head of Imaging with the assignment to establish and lead a worldwide imaging research strategy for Merck Research Laboratories. Matilda Bingham is currently Team Leader in the Medicinal Chemistry Department, MSD- 8 years research experience in neuroscience research in a pharmaceutical setting, participating and leading teams in the neuroscience area, specialising in the transporter and GPCR target classes.

Details Book

Author : Zoran Rankovic
Publisher : Royal Society of Chemistry
Data Published : 31 October 2012
ISBN : 1849733651
EAN : 9781849733656
Format Book : PDF, Epub, DOCx, TXT
Number of Pages : 590 pages
Age + : 15 years
Language : English
Rating :

Reviews Drug Discovery for Psychiatric Disorders

17 Comments Add a comment

Related eBooks Download

  • Management of Treatment-resistant Major Psychiatric Disorders free pdfManagement of Treatment-resistant Major Psychiatric Disorders

    Although there are a variety of textbooks and manuals of psychiatric disorders. few have focused on the management of treatment-resistant patients. Those that exist have largely focused on treatment-resistant depression and even these are now largely outdated..

  • Gabbard's Treatments of Psychiatric Disorders free pdfGabbard's Treatments of Psychiatric Disorders

    The definitive treatment textbook in psychiatry. this fifth edition of Gabbard's Treatments of Psychiatric Disorders has been thoroughly restructured to reflect the new DSM-5(R) categories. preserving its value as a state-of-the-art resource and increasing its utility in the field..

  • Medical Illness and Schizophrenia free pdfMedical Illness and Schizophrenia

    Despite growing awareness in the psychiatric community of the multifaceted medical needs of the severely mentally ill. statistics show that as much as 60% of all schizophrenia patients die prematurely from nonpsychiatric medical conditions -- in part because many physicians have not yet recognized how to properly treat common diseases and illnesses within this complex patient population..

  • Drug Therapy and Mood Disorders free pdfDrug Therapy and Mood Disorders

    Need to know more about a specific condition. These introductory volumes provide readable overviews of brain chemistry and function. the history of psychiatric drug treatment. possible adverse reactions..

  • Contemporary Neuropsychiatry free pdfContemporary Neuropsychiatry

    Neuropsychiatry explores the complex relationship between behavior and brain function from the interdisciplinary perspectives of psychology. neurology. and psychiatry. Researchers in the field investigate the psychiatric symptoms of neurological disorders and study psychiatric illnesses as brain disorders..

  • Drug Discovery for Psychiatric Disorders free pdfDrug Discovery for Psychiatric Disorders

    . The discovery and development of effective medicines for the treatment of psychiatric disorders such as schizophrenia and depression has been heralded as one of the great medical achievements of the